 |
|
|
|
|
|
 |
Therapeutic |
|
|
| Title |
 |
Publication Date |
 |
Price |
|
|
|
|
Vaccines: The World Market
|
February 2009 |
£2015 |
Pipeline Insight: Nosocomial Vaccines
Minefield or Goldmine?
|
April 2008 |
£6000 |
Pipeline Insight: Breast Cancer
Recent approvals increase pressure on pipeline candidates
|
April 2008 |
£6000 |
Pipeline Insight: Non-Small Cell Lung Cancer
Pipeline set to offer only modest improvements
|
April 2008 |
£6000 |
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics
|
April 2008 |
£1795 |
The Future of Targeted Therapeutics
Key Technologies, New Therapy Area Applications and Leading Players
|
March 2008 |
£1995 |
Antiviral Therapeutics
Technologies, Markets and Companies
|
March 2008 |
£1390 |
Vaccines
|
March 2008 |
£600 |
Neuroprotection
Drugs, Markets and Companies
|
March 2008 |
£1740 |
Drug Delivery in Central Nervous System Disorders
Technologies, Markets and Companies
|
March 2008 |
£1240 |
Pathology & Therapeutics for Pharmacists
3rd Edition
|
February 2008 |
£45 |
Standard and Speciality Medical Beds and Therapeutic Surfaces Worldwide
|
February 2008 |
£990 |
The Gastrointestinal Market Outlook To 2012
|
October 2007 |
£1495 |
Decoding Big Pharma's R&D Strategy in Oncology
|
September 2007 |
£1665 |
Decoding Big Pharma's R&D Strategy in Oncology
|
September 2007 |
£1665 |
Decoding Big Pharma's R&D Strategy in Oncology
|
September 2007 |
£1665 |
The World Market for Gynaecology
2007-2017
|
September 2007 |
£3200 |
Obesity Drug Discoveries: what the future holds + Obesity Tracker
|
August 2007 |
£995 |
Obesity Drug Discoveries: what the future holds
|
August 2007 |
£1425 |
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010
Key market forecasts and growth opportunities
|
August 2007 |
£895 |
Immunomodulators
Therapeutic Needs, Pipelines & Prospects
|
August 2007 |
£1495 |
Anti-Obesity Treatments 2007-2012 - A blockbuster target market
|
July 2007 |
£1799 |
Female Sexual Dysfunction
Prescription Drug Pipeline Overview 2007
|
July 2007 |
£2000 |
Future Product Opportunities in Cosmeceuticals
Innovation in food and drinks with beauty benefits
|
July 2007 |
£995 |
Cell Therapy Markets
|
July 2007 |
£1690 |
Global Vaccine Market Outlook (2007-2010)
|
June 2007 |
£795 |
Analytical Tool - Targeted Therapeutics: Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
|
May 2007 |
£2105 |
Women's Health Market Outlook to 2011
|
May 2007 |
£1495 |
The Women's Health Market Outlook to 2011
|
April 2007 |
£1495 |
Epigenomics
Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics
|
March 2007 |
£2410 |
Global Markets for Antifungal Agents
|
March 2007 |
£2410 |
Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007, The
|
January 2007 |
£1115 |
Monoclonal Antibodies 2007
Competitive Landscape & Pipeline Insight
|
January 2007 |
£1115 |
Triple Analysis: Apoptosis Agents, Antibodies and Vaccines in Oncology
|
December 2006 |
£2340 |
Global Protein Therapeutics Market, The
Market Dynamics and Pipeline Analysis
|
December 2006 |
£1490 |
Therapeutic Monoclonal Antibodies, 2006-2011
Maximising the Growth Potential of a Stocked Pipeline
|
December 2006 |
£1999 |
Therapeutic Radiopharmaceuticals Markets
Sector Snapshot
|
December 2006 |
£250 |
Stakeholder Opinions: Hormonal Contraceptives
New directions in a competitive market
|
November 2006 |
£2000 |
Anti Addiction Therapies, 2006-2011- The Pharmaceutical Industry's Next Viagra?
|
October 2006 |
£1499 |
Commercial Insight: Neuropathic Pain
A Plethora of Patient Segmentation and Product Differentiation Opportunities
|
July 2006 |
£8440 |
The Future of Monoclonal Antibodies Therapeutics
Innovation in antibody engineering, key growth strategies and forecasts to 2011
|
July 2006 |
£1495 |
Enzyme Inhibitors with Broad Therapeutic Applications
|
June 2006 |
£2410 |
Lymphoma
A Therapeutic & Competitive Insight
|
May 2006 |
£1325 |
An Evaluation of Products and Technologies for Molecular Diagnostics within Oncology
|
May 2006 |
£3140 |
Partneringdesk deals and alliances in oncology
|
April 2006 |
£1250 |
U.S. Market for Gastrointestinal Pharmaceuticals
Sector Snapshot
|
March 2006 |
£250 |
Chinese Markets for Vaccines
|
March 2006 |
£1985 |
Strategic Outlook on Protein Kinase Inhibitors in Oncology
|
February 2006 |
£1325 |
Antiageing and Life Enhancement Pharmacotherapeutics
|
January 2006 |
£4600 |
Survey of Private Companies Active in CNS & PNS Drug R&D, A
|
January 2006 |
£1045 |
How to Succeed In Personalized Medicine
by Using Tools and Technologies Which Companies and Technologies are Profiting From a Favorable Regulatory Environment
|
January 2006 |
£2750 |
Oncogenomics
The Future of Cancer Care
|
January 2006 |
£1945 |
Stakeholder Perspectives: Influenza Vaccines
Flying back Into Flu
|
December 2005 |
£4350 |
Stem Cell Therapies and Regenerative Medicine
Current Applications and Future Possibilities
|
December 2005 |
£2255 |
Global Image Dermatology Drug Market, 2005-2012, The
High-Growth Opportunities in Aesthetic Medicine
|
November 2005 |
£1900 |
Aromatherapy Science
A Guide for Healthcare Professionals
|
November 2005 |
£45 |
Market for Organ and Tissue Transplantation and Alternatives; The
|
October 2005 |
£2255 |
Analytical Tool - Analysis of Colorectal Cancer R&D
The Complete Guide
|
September 2005 |
£2105 |
Handbook of Biogeneric Therapeutic Proteins
Regulatory, Manufacturing, Testing, and Patent Issues
|
August 2005 |
£130 |
Major Milestones: Female Sexual Dysfunction
|
August 2005 |
£3000 |
Directory of Therapeutic Enzymes
|
August 2005 |
£92 |
Respiratory Handbook 2005-15
Novartis Moving Into the Major League
|
June 2005 |
£2000 |
Inflammatory Disease Therapeutics
Pipelines and Competitive Dynamics
|
June 2005 |
£2140 |
Pricing Drivers Of Combination Therapies: Product Premiums Scarcely Seen
|
May 2005 |
£4000 |
Oncology Brand Commercialization
Resource Allocation
|
May 2005 |
£1665 |
New Therapeutics and Diagnostics for Women’s Disorders
|
May 2005 |
£2255 |
Radiation-based Therapy and Therapeutic Imaging
|
May 2005 |
£2255 |
Therapeutic Vaccines for Cancer
On the Threshold of Success
|
April 2005 |
£2750 |
Pipeline Insight: Hematological malignancies
Targeted treatments and immunotherapy infuse new blood
|
April 2005 |
£6000 |
HRT: Major Milestones
Current Perspectives on HRT and Menopause
|
March 2005 |
£2650 |
Therapeutic Proteins
|
February 2005 |
£1999 |
Market Leaders in Oncology 2004
Roche and Genentech Continue to Blaze a Trail
|
January 2005 |
£2000 |
Top CNS Portfolios in 2004
The Industry Gold Standards
|
January 2005 |
£1000 |
Vaccines Market Outlook, The
Market analysis of future growth and leading players by sector
|
January 2005 |
£1495 |
The Antivirals Market Outlook
Market analysis of future growth and leading players by sector
|
January 2005 |
£1495 |
Antithrombotics
Sanofi-Aventis the Dominant Player
|
December 2004 |
£8000 |
Trends in PCI
PCI vs. Thrombolysis: The Debate
|
December 2004 |
£1000 |
Stakeholder Opinions: HIV Vaccines
The Emperor Has No Clothes
|
December 2004 |
£2000 |
Patient Compliance in Psychiatry
From Patient Acquisition to Patient Retention
|
December 2004 |
£8000 |
Women’s Health Diagnostic Tests
|
December 2004 |
£495 |
Pipeline Insight: PAD
Gene Therapy Going Out on a Limb
|
November 2004 |
£6000 |
COX-2 Inhibitors
Biology, Therapeutic Agents & Markets
|
November 2004 |
£400 |
Cosmeceuticals to 2008
|
November 2004 |
£2035 |
Psychiatric Drugs
New Developments and Market Analysis by Drug Class and Clinical Indication
|
November 2004 |
£2750 |
World Market for Vaccines, The
|
November 2004 |
£1765 |
Cardiovascular Disease
Current Research, Devices, and Trends
|
November 2004 |
£2750 |
Pipeline Insight: Nociceptive Pain
Safety Profile Uppermost in Crowded Market
|
October 2004 |
£6000 |
Development and Commercialisation of Protein Therapeutics
Technologies, pipelines and forecasts
|
September 2004 |
£1045 |
Stakeholder Insight: ADHD
Prescriber Attention Still Held by Short Acting Stimulant Drugs
|
September 2004 |
£8000 |
Vaccines to 2008
|
August 2004 |
£2035 |
Pipeline Insight: Colorectal Cancer
Avastin and Erbitux Pave The Way For Pipeline Targeted Therapies
|
July 2004 |
£6000 |
Vaccines in the 21st Century
New Approaches, Targets, and Market Vitality
|
June 2004 |
£2750 |
Therapeutic Protein Industry
Therapeutic protein industry - value mapping
|
January 2004 |
£60 |
Chronotherapeutics
|
September 2003 |
£75 |
Asthma Therapeutics
New treatment options and emerging drug discovery targets
|
April 2003 |
£330 |
5-HT7 antagonists
Novel molecules for the unmet migraine prophylaxis market
|
March 2003 |
£330 |
Chinese Markets for Vaccine
|
March 2003 |
£1985 |
Emerging Cancer Therapies
Markets and Business Opportunities
|
June 2002 |
£875 |
New Anticoagulant Therapies
A Market Briefing
|
October 2001 |
£450 |
World Market for Neurotherapeutic Drugs; The
|
September 2001 |
£1325 |
Protein Therapeutics Market; The
The Science and Business of a Growing Sector
|
June 2001 |
£1970 |
Breast Cancer
Market Opportunities for Novel Diagnostic and Therapeutic Approaches
|
June 2001 |
£4950 |
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments
World Market
|
May 2001 |
£1005 |
Anti-Infectives
World Market, 2nd. Ed., Vol. I
|
March 2001 |
£1510 |
World Market for Psychotherapeutic Drugs, The
|
January 2001 |
£1765 |
|
|
|
|
